Log In
BCIQ
Print this Print this
 

Lorexys (S1P-104)

  Manage Alerts
Collapse Summary General Information
Company S1 Biopharma Inc.
DescriptionOral fixed-dose enteric formulation of a combination of bupropion and trazodone
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationSexual dysfunction
Indication DetailsTreat female sexual dysfunction (FSD); Treat hypoactive sexual desire disorder (HSDD) in women
Regulatory Designation
PartnerChong Kun Dang Pharmaceutical Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/08/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today